A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for the cognitive impairment of schizophrenia

被引：2
|
作者：
Tugal, O [1 ]
Yazici, KM [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Psychiat, TR-06100 Ankara, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91990-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia
    Tugal, O
    Yazici, KM
    Yagcioglu, AEA
    Gogus, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (02): : 117 - 123
  • [2] A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia
    Fadaii, F.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S131 - S132
  • [3] A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia
    Niknam, Z.
    Fadaii, F.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S280 - S281
  • [4] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (05) : 349 - 357
  • [5] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 9 - 9
  • [6] A randomised, double-blind, placebo controlled, cross-over trial of adjunctive L-arginine in schizophrenia
    Kocyigit, Y.
    Ayhan, Y.
    Yoca, G.
    Karahan, S.
    Yazici, M. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S484 - S484
  • [7] A 10-WEEK, DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER TRIAL OF ADJUNCTIVE MODAFINIL FOR NEUROCOGNITIVE IMPAIRMENTS IN SCHIZOPHRENIA
    Letourneau, Karine
    Demers, M. F.
    Simard, M.
    Emond, C.
    Roy, M. A.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 283 - 283
  • [8] A 12 week, double-blind, placebo controlled trial of donepezil adjunctive to haloperidol for the cognitive impairments in patients with chronic schizophrenia
    Kim, Y
    Shim, JC
    Suh, YS
    Lee, BJ
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 490 - 491
  • [9] A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia (vol 51, pg 349, 2002)
    Friedman, JI
    Adler, DN
    Howanitz, E
    Harvey, PD
    Brenner, G
    Temporini, H
    White, L
    Parrella, M
    Davis, KL
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 51 (12) : 1014 - 1014
  • [10] Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: A double-blind, placebo-controlled study
    Fagerlund, Birgitte
    Soholm, Bettina
    Fink-Jensen, Anders
    Lublin, Henrik
    Glenthoj, Birte Y.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2007, 30 (01) : 3 - 12
12345